The Knowledge Filter and Economic Growth: The Role of Scientist Entrepreneurship
David Bruce Audretsch, Taylor Aldridge, Alexander Oettl
Indiana University Bloomington Indiana University Georgia Institute of Technology
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
This study examines the prevalence and determinants of the commercialization of research by the top twenty percent of university scientists funded by grants from the National Cancer Institute (NCI). Because the two publicly available modes of scientist commercialization - patents and Small Business Innovation Research (SBIR) grants - do not cover the full spectrum of commercializing activities undertaken by university scientists, the study also includes two additional measures obtained from detailed scientist interviews: licensing of intellectual property and starting a new firm. These measures are used to assess both the prevalence and determinants of scientist commercialization of research. In particular, two distinct routes for commercializing scientist research are identified, the Technology Transfer Office (TTO) route and the entrepreneurial route, which does not involve assigning a patent to the university. This study in no way provides an assessment or judgment about the efficacy of the TTO. Rather, this study highlights the extent to which additional commercialization of research takes place, suggesting that the contribution of universities to U.S. innovation and ultimately economic growth may be greater than had previously been believed. Specific empirical findings suggest that: Scientists receiving funding from the National Cancer Institute exhibit a robust propensity to commercialize their research. However, the prevalence of commercialization depends highly upon the actual mode of commercialization. Some modes of commercialization, such as patents, are more prevalent, while other modes, such as funding by the SBIR program are rarely used. Scientist entrepreneurship is the sleeping giant of commercializing university research. More than one in four patenting NCI scientists have started a new firm. Two paths for commercialization of scientist research are identified - the TTO route and the entrepreneurial route. Scientists who select the TTO route by commercializing their research through assigning all patents to their university TTO account for 70 percent of NCI patenting scientists. Scientists who choose the entrepreneurial route to commercialize their research, in that they do not assign patents to their university TTO, comprise 30 percent of patenting NCI scientists. Social capital enhances the propensity for scientists to commercialize their research. The impact of social capital is particularly high for the commercialization mode of scientist entrepreneurship. For scientists who perceive that they are helped by their Technology Transfer Office, licensing is the most prevalent mode of commercialization. For scientists who perceive that they are not helped by their Technology Transfer Office, entrepreneurship emergences as a much more important mode of commercialization. Scientists choosing the entrepreneurial route to commercialize their research, by not assigning patents to their university to commercialize research, tend to rely on the commercialization mode of entrepreneurship. By contrast, scientists who select the TTO route by assigning their patents to the university tend to rely on the commercialization mode of licensing.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
经济 / 管理Entrepreneurship Studies and Influences
Intellectual Property and Patents · Research, Science, and Academia
参考文献 3
此处列出前 3 条
引用本文 108
按被引量排序,此处列出前 3 条